{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P15056",
      "entity_text" : "BRAF",
      "features" : [ {
        "to_base" : "A",
        "site" : 0,
        "feature_type" : "mutation",
        "evidence" : "mutations"
      } ],
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ02827",
      "entity_text" : "PH8",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Alternatively, a serrated or BRAF pathway (families PH3 and PH8) where SSA or TSA will probably lead to MSI-H cancer carrying BRAF mutations may also occur (XREF_FIG, upper panel).",
  "reading_complete" : "2020-08-03T15:15:29Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T15:09:57Z",
  "trigger" : "lead",
  "evidence" : [ "PH8) where SSA or TSA will probably lead to MSI-H cancer carrying BRAF" ],
  "pmc_id" : "4990292",
  "score" : 0
}